HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas".

AbstractBACKGROUND:
Allogeneic stem cell transplantation (alloSCT) is a treatment option for primary cutaneous T-cell lymphomas that may induce long-lasting complete remissions. Little information is available on safety and efficacy.
PATIENTS AND METHODS:
We retrospectively reviewed the data from patients with primary cutaneous T-cell lymphoma treated in the Departments of Dermatology of the Universities of Bochum, Mannheim and Cologne who received subsequent alloSCT between 2005 and 2012.
RESULTS:
Nine patients with aggressive primary cutaneous T-cell-lymphoma received alloSCT. With a follow-up of 14 to 36 months after transplantation, 4 patients are alive and in complete remission. Two patients had recurrent disease post-transplantation, which was successfully treated with donor lymphocyte infusions. Non-relapse mortality was observed in three patients in advanced disease stages within six months after alloSCT. One patient showed only partial remission and died of disease after 32 months and one patient died 26 months after alloSCT with cause of death unknown.
CONCLUSIONS:
This report documents the possible benefit of a graft-versus-lymphoma effect in primary cutaneous T-cell lymphoma, as has been observed for other T-cell malignancies and emphasizes that alloSCT warrants further studies in this setting.
AuthorsRose K C Moritz, Markus Ditschkowski, Claus-Detlev Klemke, Sarah Terras, Max Schlaak, Martin Knorr, Sebastian Theurich, Ute Hegenbart, Bernhard Kremens, Dietrich W Beelen, Markus Stücker, Alexander Kreuter, working group "cutaneous lymphomas" of the Arbeitsgemeinschaft für Dermatologische Forschung (ADF), Germany
JournalJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (J Dtsch Dermatol Ges) Vol. 12 Issue 1 Pg. 39-46 (Jan 2014) ISSN: 1610-0387 [Electronic] Germany
PMID24134607 (Publication Type: Case Reports, Journal Article)
Copyright© 2014 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
Topics
  • Adult
  • Child
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, T-Cell, Cutaneous (pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (pathology, prevention & control)
  • Skin Neoplasms (pathology, surgery)
  • Stem Cell Transplantation (methods)
  • Transplantation, Homologous (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: